ArticleMultidisciplinary respiratory medicine2026
The Evaluation initiative: management of rhinitis by Italian otorhinolaryngologists.
Article in Multidisciplinary respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRhinitis is a common medical condition characterized by different phenotypes. Allergic (AR) and non-allergic (NAR) rhinitis share common type 2 inflammation. The present Italian educational activity investigated the clinical characteristics and treatments of patients with rhinitis managed by Italian otorhinolaryngologists.
methodsGlobally 117 well-matched otorhinolaryngologists attended this educational activity. This initiative consisted of a preliminary questionnaire to participants, one educational webinar, a field training session, and one in-person meeting. Demographic and clinical parameters, and treatments (previous and current) were collected.
resultsThe otorhinolaryngologists collected data of 1238 patients with rhinitis (814 with AR and 424 with NAR). Nasal obstruction was the most common symptom, present in 88% of patients. Quality of life was impaired in about 80% of patients. Concomitant presence of nasal obstruction and impaired quality of life was associated with more severe symptoms. Intranasal corticosteroids (INCS) were the preferred treatment for participants. This educational initiative changed participants' attitudes and increased the percentage of INCS prescriptions, mainly for budesonide, and the use of INCS cycles.
conclusionsThe present iterative educational initiative yielded practical insights into the clinical characteristics of patients with type 2 rhinitis. Nasal obstruction and impaired quality of life are common clinical characteristics among patients visited. A close link between inflammation and associated symptoms justifies the frequent use of INCS. In this context, budesonide was perceived as a valuable option in managing AR and NAR patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.